Elyse E. Lower

11.7k total citations
164 papers, 7.0k citations indexed

About

Elyse E. Lower is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elyse E. Lower has authored 164 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Physiology, 107 papers in Pulmonary and Respiratory Medicine and 32 papers in Oncology. Recurrent topics in Elyse E. Lower's work include Sarcoidosis and Beryllium Toxicity Research (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (91 papers) and HER2/EGFR in Cancer Research (17 papers). Elyse E. Lower is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (119 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (91 papers) and HER2/EGFR in Cancer Research (17 papers). Elyse E. Lower collaborates with scholars based in United States, United Kingdom and Netherlands. Elyse E. Lower's co-authors include Robert P. Baughman, Roland M. du Bois, Robert P. Baughman, Deborah Bradley, Marjolein Drent, Robbin Blau, Jolanda De Vries, Adam H. Kaufman, Peter J. Engel and Nadera Sweiss and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elyse E. Lower

157 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elyse E. Lower United States 49 4.7k 4.7k 1.1k 924 865 164 7.0k
Nadera Sweiss United States 36 2.0k 0.4× 1.8k 0.4× 445 0.4× 286 0.3× 319 0.4× 132 3.9k
Pilar Brito‐Zerón Spain 47 3.2k 0.7× 1.1k 0.2× 1.4k 1.3× 538 0.6× 225 0.3× 120 8.8k
Elisabeth Brouwer Netherlands 50 1.7k 0.4× 4.5k 1.0× 386 0.4× 547 0.6× 109 0.1× 240 9.4k
Luc Mouthon France 61 2.0k 0.4× 7.2k 1.5× 1.9k 1.8× 330 0.4× 112 0.1× 389 13.2k
Lorraine Harper United Kingdom 48 1.7k 0.4× 5.7k 1.2× 527 0.5× 206 0.2× 100 0.1× 192 8.3k
Yannick Allanore France 69 1.0k 0.2× 5.5k 1.2× 3.6k 3.4× 887 1.0× 135 0.2× 480 16.7k
Ingeborg M. Bajema Netherlands 51 845 0.2× 3.4k 0.7× 614 0.6× 291 0.3× 117 0.1× 181 9.7k
Xavier Puéchal France 46 1.7k 0.4× 3.0k 0.6× 759 0.7× 272 0.3× 88 0.1× 213 7.1k
Brett M. Elicker United States 38 2.0k 0.4× 5.0k 1.1× 802 0.8× 388 0.4× 46 0.1× 102 6.5k
Wim Wuyts Belgium 39 1.6k 0.3× 4.1k 0.9× 642 0.6× 268 0.3× 107 0.1× 199 5.3k

Countries citing papers authored by Elyse E. Lower

Since Specialization
Citations

This map shows the geographic impact of Elyse E. Lower's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyse E. Lower with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyse E. Lower more than expected).

Fields of papers citing papers by Elyse E. Lower

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyse E. Lower. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyse E. Lower. The network helps show where Elyse E. Lower may publish in the future.

Co-authorship network of co-authors of Elyse E. Lower

This figure shows the co-authorship network connecting the top 25 collaborators of Elyse E. Lower. A scholar is included among the top collaborators of Elyse E. Lower based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyse E. Lower. Elyse E. Lower is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeny, Florence, Dominique Valeyre, Elyse E. Lower, & Robert P. Baughman. (2025). Advanced pulmonary sarcoidosis. Journal of Autoimmunity. 152. 103397–103397. 1 indexed citations
2.
Jeny, Florence, Deepak Talwar, Ogugua Ndili, et al.. (2024). Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis. Respiratory Medicine and Research. 86. 101127–101127.
3.
Zhao, Mengmeng, et al.. (2023). SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis. Respiratory Research. 24(1). 219–219. 8 indexed citations
4.
Baughman, Robert P., et al.. (2022). Dual Medical Therapy for Treatment of Arrhythmias in Cardiac Sarcoidosis. Journal of Innovations in Cardiac Rhythm Management. 13(11). 5244–5254. 3 indexed citations
5.
Ndili, Ogugua, Elyse E. Lower, & Robert P. Baughman. (2021). Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Review of Clinical Pharmacology. 14(2). 179–210. 14 indexed citations
6.
Yang, Yongguang, Zhenhua Luo, Syn Kok Yeo, et al.. (2021). Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer. Cell Reports. 34(10). 108822–108822. 18 indexed citations
7.
Gerke, Alicia K., Elyse E. Lower, А. A. Vizel, et al.. (2021). The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Respiratory Medicine. 187. 106564–106564. 33 indexed citations
8.
Baughman, Robert P., et al.. (2021). The Value of a Patient Global Assessment in Management of Sarcoidosis. Lung. 199(4). 357–362. 3 indexed citations
9.
Kittaneh, Muaiad, Sunil Badve, Humberto Caldera, et al.. (2020). Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical Breast Cancer. 20(3). 183–193. 12 indexed citations
10.
Mahtani, Reshma, Sunil Badve, Humberto Caldera, et al.. (2019). A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer. Clinical Breast Cancer. 20(3). e251–e260. 17 indexed citations
11.
Abraham, Jame, Humberto Caldera, Robert E. Coleman, et al.. (2018). Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast Cancer Research and Treatment. 169(1). 1–7. 9 indexed citations
12.
Lower, Elyse E., et al.. (2018). Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study. Cancer Chemotherapy and Pharmacology. 82(1). 165–170. 5 indexed citations
13.
Yang, Yongguang, Yijuan Zhang, Dan Zhao, et al.. (2017). HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1. Cancer Research. 78(2). 422–435. 27 indexed citations
14.
Lower, Elyse E., et al.. (2017). Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site. Breast Cancer Targets and Therapy. Volume 9. 515–520. 28 indexed citations
15.
Baughman, Robert P., Marc A. Judson, Elyse E. Lower, et al.. (2016). Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.. PubMed. 32(4). 289–95. 33 indexed citations
16.
Baughman, Robert P., Hilario Nunès, Nadera Sweiss, & Elyse E. Lower. (2013). Established and experimental medical therapy of pulmonary sarcoidosis. European Respiratory Journal. 41(6). 1424–1438. 87 indexed citations
17.
Baughman, Robert P. & Elyse E. Lower. (2012). Sarcoidosis Mortality. American Journal of Respiratory and Critical Care Medicine. 185(4). 462–462. 1 indexed citations
18.
Baughman, Robert P., et al.. (2009). ARMODAFINIL (R-MODAFINIL) FOR FATIGUE IN SARCOIDOSIS: NOT JUST TREATING HYPERSOMNOLENCE. CHEST Journal. 136(4). 128S–128S. 2 indexed citations
19.
Baughman, Robert P., Elyse E. Lower, Deborah Bradley, Lawrence A. Raymond, & Adam H. Kaufman. (2005). Etanercept for Refractory Ocular Sarcoidosis. CHEST Journal. 128(2). 1062–1067. 89 indexed citations
20.
Heffelfinger, Sue C., Elyse E. Lower, Mary Ann Miller, & Cecilia M. Fenoglio‐Preiser. (1996). Plasma Membrane Phosphotyrosine, Her2-NEU, and Epidermal Growth Factor Receptor in Human Breast Cancer. American Journal of Clinical Oncology. 19(6). 552–557. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadera Sweiss Breakdown of academic impact, for papers by Pilar Brito‐Zerón Breakdown of academic impact, for papers by Elisabeth Brouwer Breakdown of academic impact, for papers by Luc Mouthon Breakdown of academic impact, for papers by Lorraine Harper Breakdown of academic impact, for papers by Yannick Allanore Breakdown of academic impact, for papers by Ingeborg M. Bajema Breakdown of academic impact, for papers by Xavier Puéchal Breakdown of academic impact, for papers by Brett M. Elicker Breakdown of academic impact, for papers by Wim Wuyts
Rankless by CCL
2026